¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"tumor suppressor gene"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 3
¿µ¹® mucinous tumor ÇÑ±Û Á¡¾×Á¾¾ç
¼³¸í   
  Á¡¾×À¸·Î ±¸¼ºµÈ Á¾¾çÀ» ¸»Çϴµ¥ ÁַΠ¿©¼ºÀÇ ³­¼Ò¿¡¼­ ¹ß»ýÇϴ ³¶¼º(¹°ÁָӴϰ°Àº Á¾¾çÀ» ¸»ÇÔ) Á¾¾ç¿¡¼­ ¸¹ÀÌ º¼ ¼ö ÀÖ´Ù.
¿µ¹® tumor ÇÑ±Û Á¾¾ç
¼³¸í   
  Á¶ÀýÇÒ ¼ö ¾øÀÌ °è¼Ó ÁøÇàµÇ´Â ¼¼Æ÷ºÐ¿­¿¡ ÀÇÇÑ Á¶Á÷ÀÇ »õ·Î¿î Áõ½Ä ¹× Áõ´ë. ½Å»ý¹°.
  
  (1) ºÐ·ù
  
    A. Ä§À±°ú ÀüÀÌÀÇ À¯¹«¿¡ µû¶ó
  
      i)¾ç¼ºÁ¾¾ç: Ä§À±°ú ÀüÀ̰¡ ¾ø°í ¿ªÇü¼ºÀÌ ³·Àº ¼¼Æ÷·Î ±¸¼ºµÊ. ´ë°³ Ä¡·á¿¡ ¹ÝÀÀÀÌ ³ô°í, »ý¸í¿¡ Å©°Ô ÁöÀåÀÌ ¾øÀ¸¸ç, Àç¹ßÇϴ °æ¿ìµµ Àû´Ù. Áõ»óÀº ´ÜÁö ÁÖÀ§Á¶Á÷¿¡ ´ëÇÑ ¾Ð¹ÚÁ¤µµÀÌ´Ù.
  
      ii)¾Ç¼ºÁ¾¾ç: Ä§À±°ú ÀüÀ̰¡ ÀÖ°í ÅðÈ­µµ°¡ ³ôÀº ¼¼Æ÷·Î ±¸¼ºµÊ. ±â¿ø¼¼Æ÷°¡ »óÇÇÁ¶Á÷ÀÏ °æ¿ì ¾ÏÁ¾, ºñ»óÇǼºÀÏ °æ¿ì À°Á¾À¸·Î ³ª´©±âµµ ÇÑ´Ù. Ä¡·á¿¡ Àß ¹ÝÀÀÇÏÁö ¾Ê°í, Àç¹ßÀ» Àß Çϸç, »ýÁ¸À²ÀÌ ³·´Ù. ÈçÈ÷ ¸»Çϴ ¡°¾Ï¡±À» ÀǹÌÇÑ´Ù.
  
    B. Á¶Á÷ÇÐÀû Æ¯Â¡¿¡ µû¶ó »ùÁ¾, Áö¹æÁ¾, ±ÙÁ¾ µîÀ¸·Î ³ª´©±âµµ ÇÑ´Ù.
  
  (2) º´¸®Á¶Á÷ÇÐÀû Æ¯Â¡
  
    A. À°¾ÈÀû ¼Ò°ß
  
  µ¢¾î¸®¸¦ Çü¼ºÇϱ⵵ Çϰí Á¤»óÁ¶Á÷¿¡ ½º¸çµéµíÀÌ ÆÇ»ó±¸Á¶¸¦ ÀÌ·ç±âµµ Çϴ µî ´Ù¾çÇÑ ÇüŸ¦ º¸ÀδÙ. ¾ç¼ºÀÇ °æ¿ì ÇǸ·À» °¡Áø °æ¿ì°¡ ¸¹°í ¾Ç¼ºÀÇ °æ¿ì ¾ø´Â °æ¿ì°¡ ¸¹´Ù.
  
  À°¾È¼Ò°ß¿¡ µû¶ó ´ÙÀ½°ú °°ÀÌ ³ª´«´Ù. ³¶¼º, À¶±â¼º, ±«»ç¼º, Æú¸³¸ð¾ç, ±Ë¾çÇü µîÀÌ ÀÖ´Ù. ¶Ç´Â ¼¼Æ÷ÀÇ Å©±â¿Í ¸ð¾çÀÌ ºñÁ¤»óÀûÀΠÇüÅ·Πº¯È­ÇÑ´Ù. ÇÙÀÇ ±Ø¼ºÀÌ »ç¶óÁö°í ÇÙÀÇ ¿°»ö¼ºÀ̠£¾îÁø´Ù. ¼¼Æ÷ÁúÀÇ ¿°»ö¼ºµµ º¯È­Çϸ砼¼Æ÷µé°£ÀÇ ¼¼Æ÷ÁֱⰡ ¸Å¿ì ´Ù¾çÇØÁ® ¸¹Àº ¼¼Æ÷ºÐ¿­À» º¸ÀδÙ. ÀÌ·¯ÇÑ ÀÏ·ÃÀÇ º¯È­¸¦ ¿ªÇü¼ºÀ̶ó ÇÑ´Ù. ¿ªÇü¼ºÀÇ Á¤µµ¿¡ µû¶ó Á¶Á÷ÇÐÀû µî±ÞÀ» ³ª´«´Ù. ¶ÇÇÑ °¢ Á¾¾ç¿¡ µû¶ó °¢±â ´Ù¸¥ º´¸®Á¶Á÷ÇÐÀû ¸íĪÀ» ºÙÀδÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mixed germ cell tumor
    È¥ÇÕÁ¾ÀÚ¼¼Æ÷Á¾¾ç
  • mixed tumor
    È¥ÇÕÁ¾¾ç
  • malignant tumor
    ¾Ç¼ºÁ¾¾ç
  • melanotic neuroectodermal tumor
    ¸á¶ó´Ñ½Å°æ¿Ü¹è¿±Á¾¾ç, Èæ»ö½Å°æ¿Ü¹è¿±¼ºÁ¾¾ç
  • mesenchymal tumor
    Áß°£¿±Á¾¾ç
  • mesodermal tumor
    Á߹迱Á¾¾ç
  • metastatic tumor
    ÀüÀÌÁ¾¾ç
  • neuroepithelial tumor
    ½Å°æ»óÇÇÁ¾¾ç
  • nonfunctioning tumor
    ºñ±â´ÉÁ¾¾ç
  • odontogenic tumor
    Ä¡¿ø¼ºÁ¾¾ç
  • organoid tumor
    Àå±â¸ð¾çÁ¾¾ç
  • phyllodes tumor
    ¿±»óÁ¾¾ç
  • polypoid tumor
    Æú¸³¸ð¾çÁ¾¾ç
  • primitive neuroectodermal tumor
    ¿ø½Ã½Å°æ¿Ü¹è¿±Á¾¾ç
  • peripheral primitive neuroectodermal tumor
    ¸»ÃÊ¿ø½Ã½Å°æ¿Ü¹è¿±Á¾¾ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nonfunctioning tumor
    ºñ±â´ÉÁ¾¾ç
  • occult primary tumor
    Àẹ¿ø¹ßÁ¾¾ç
  • odontogenic tumor
    Ä¡¾ÆÅ¿Á¾¾ç, Ä¡¿øÁ¾¾ç
  • peripheral primitive neuroectodermal tumor
    ¸»ÃÊ¿ø½Ã½Å°æ¿Ü¹è¿±Á¾¾ç
  • phyllodes tumor
    ¿±»óÁ¾¾ç
  • primitive neuroectodermal tumor
    ¿ø½Ã½Å°æ¿Ü¹è¿±Á¾¾ç
  • renin-secreting juxtaglomerular tumor
    ·¹´ÑºÐºñÅ丮°çÁ¾¾ç, ·¹´ÑºÐºñ»ç±¸Ã¼¿·Á¾¾ç
  • Sertoli-Leydig tumor
    ¼¼¸£Å縮¶óÀ̵ðÈ÷ Á¾¾ç
  • smooth muscle tumor
    ÆòȰ±ÙÁ¾¾ç
  • solid tumor
    °íÇüÁ¾¾ç
  • stromal tumor
    ¹öÆÀÁúÁ¾¾ç, ±âÁúÁ¾¾ç
  • subareolar location of tumor
    Á¥²ÉÆÇ¹ØÁ¾¾ç
  • submucosal tumor
    Á¡¸·¹ØÁ¾¾ç
  • trophoblastic tumor
    ¿µ¾ç¸·Á¾¾ç
  • Wilms' tumor
    Àª¸§ÁîÁ¾¾ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gene pool
    À¯ÀüÀÚÇ®
  • gene recombination
    À¯ÀüÀÚÀçÁ¶ÇÕ
  • gene redundancy
    À¯ÀüÀÚ¿©À¯
  • gene regulation
    À¯ÀüÀÚÁ¶Àý
  • gene replacement
    À¯ÀüÀÚ±³È¯
  • gene segment
    À¯ÀüÀÚÁ¶°¢
  • gene transfection
    À¯ÀüÀÚÀü´Þ°¨¿°
  • gene transfer
    À¯ÀüÀÚÀü´Þ
  • gene translocation
    À¯ÀüÀÚÀüÀ§
  • gonosomal gene
    ¼º¿°»öüÀ¯ÀüÀÚ
  • histocompatibility gene
    Á¶Á÷ÀûÇÕÇ׿øÀ¯ÀüÀÚ
  • hox gene
    Ȥ½ºÀ¯ÀüÀÚ
  • human leukocyte antigen complex gene
    »ç¶÷¹éÇ÷±¸Ç׿øº¹ÇÕüÀ¯ÀüÀÚ
  • immune response gene
    ¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
  • lethal gene
    Ä¡»çÀ¯ÀüÀÚ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gene defect
    À¯ÀüÀÚ°á¼Õ<--°á¿©>
  • gene deletion
    À¯ÀüÀÚ°á½Ç<--»èÁ¦
  • gene, mutator
    º¯ÀÌÀ¯¹ßÀ¯ÀüÀÚ
  • gene, operator
    ÀÛµ¿À¯ÀüÀÚ
  • gene, regulatory
    Á¶ÀýÀ¯ÀüÀÚ
  • gene, repressor
    ¾ïÁ¦À¯ÀüÀÚ
  • gene, structural
    ±¸Á¶À¯ÀüÀÚ
  • histocompatibility gene
    Á¶Á÷ÀûÇÕ¼º À¯ÀüÀÚ
  • histocompatibility gene
    Á¶Á÷ÀûÇÕÀ¯ÀüÀÚ.
  • immediate early gene
    Á¶±â ¹ßÇö À¯ÀüÀÚ
  • immune response gene
    ¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ.
  • immune response gene
    ¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
  • immunoglobulin (Ig) gene
    ¸é¿ª±Û·ÎºÒ¸° À¯ÀüÀÚ
  • immunoglobulin gene
    ¸é¿ª±Û·ÎºÒ¸°À¯ÀüÀÎÀÚ
  • ras gene
    ras À¯ÀüÀÚ(¡­ë¶îîí­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • atk gene
    atk À¯ÀüÀÚ(¡­ë¶îîí­)
  • autosomal gene
    º¸Åë¿°»öüÀ¯ÀüÀÚ
  • bcg gene
    bcg À¯ÀüÀÚ(¡­ë¶îîí­)
  • bcl gene
    bcl À¯ÀüÀÚ
  • bcr-c-abl gene
    bcr-c-abl À¯ÀüÀÚ
  • beta-globin gene
    º£Å¸±×·ÎºóÀ¯ÀüÀÚ(¡­ë¶îîí­)
  • c4a gene
    C4A À¯ÀüÀÚ (¡­ë¶îîí­)
  • calcitonin-gene related peptide
    Ä®½ÃÅä´ÑÀ¯ÀüÀÚ°ü·ÃÆéƼµå
  • complementary gene
    º¸Á·À¯ÀüÀÚ(ÜÍðëë¶îîí­), º¸Ã¼À¯ÀüÀÚ.
  • contiguous gene syndrome
    Á¢Ã˼º À¯ÀüÀÚ ÁõÈıº(ïÈõºàõë¶îîí­ñøý¦ÏØ)
  • contiguous gene syndrome
    ÀÎÁ¢ À¯ÀüÀÚ ÁõÈıº
  • control gene
    Á¦¾îÀ¯ÀüÀÚ(ð¤åÙë¶îîí­).
  • covering gene
    ÇǺ¹À¯ÀüÀÚ(¡­ë¶îîí­).
  • dcc gene
    DCC À¯ÀüÀÚ(¡­ë¶îîí­)
  • determinant gene
    °áÁ¤À¯ÀüÀÚ(̽ïÒë¶îîí­).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • dominant gene
    ¿ì¼º À¯ÀüÀÚ(éÐàõë¶îîí­)
  • duplicate gene
    º¹»ç À¯ÀüÀÚ(ÜÜÞÐë¶îîí­)
  • early gene
    Á¶±â À¯ÀüÀÚ (ðÄÑ¢ë¶îîí­)
  • epistatic gene
    ¿ìÀ§ À¯ÀüÀÚ (éÐêÈë¶îîí­)
  • essential gene
    Çʼö À¯ÀüÀÚ (ù±âÎë¶îîí­)
  • fused gene
    À¶ÇÕ À¯ÀüÀÚ(ë×ùêë¶îîí­)
  • fusion gene
    À¶ÇÕ À¯ÀüÀÚ(ë×ùêë¶îîí­)
  • gene
    À¯ÀüÀÚ(ë¶îîí­)
  • gene activation
    À¯ÀüÀÚ È°¼ºÈ­(ë¶îîí­üÀàõûù)
  • gene amplification
    À¯ÀüÀÚ ÁõÆø(ë¶îîí­ñòøë)
  • gene bank
    À¯ÀüÀÚ ÀºÇà(ë¶îîí­ëÞú¼)
  • gene cloning
    À¯ÀüÀÚ(ë¶îîí­) Ŭ·Î´×
  • gene cluster
    À¯ÀüÀÚ(ë¶îîí­) ¼ÛÀÌ
  • gene conversion
    À¯ÀüÀÚ Àüȯ(ë¶îîí­ï®üµ)
  • gene dosage
    À¯ÀüÀÚ ·®(ë¶îîí­Õá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • teratoid tumor
    ±âÇü¾çÁ¾¾ç
  • TNM [=Tumor-Lymphnode-Metastasis] classification
    TNMºÐ·ù ¡ìÁ¾¾ç, ¸²ÇÁÀý, ÀüÀ̵éÀ» Ç¥ÁØÀ¸·Î ÇÏ´Â ¾Ç¼ºÁ¾¾çÀÇ ºÐ·ù¹ý¡í
  • trophoblastic tumor
    ¿µ¾ç¸·Á¾¾ç
  • tumor
    Á¾¾ç, Á¾Ã¢
  • tumor cell
    Á¾¾ç¼¼Æ÷
  • tumor shadow
    Á¾¾çÀ½¿µ
  • tumor stain
    Á¾¾ç¿°»ö, Á¾¾çÁ¶¿µ
  • tumor vessel
    Á¾¾çÇ÷°ü
  • vanishing tumor
    Àϰú¼ºÁ¾¾ç»óÀ½¿µ, Àϰú¼º¿±°£Èä¼öÀú·ù(»ó)
  • Warthin's tumor
    ¿Í¸£Æ¾Á¾¾ç
  • Wilms' tumor
    Àª¸§Á¾¾ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SAI Self-Analysis Inventory; Sexual Arousability Inventory; Social Adequacy Index; suppressor of anchora...
SCA self-care agency; severe congenital anomaly; sickle-cell anemia; single-camera autostereoscopic [ima...
SF Sabin-Feldman [test]; safety factor; salt-free; scarlet fever; screen film; seminal fluid; serosal f...
SIRS soluble immune response suppressor; Structured Interview of Reported Symptoms; systemic inflammatory...
SSCA spontaneous suppressor cell activity
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SCA Suppressor cell activity
SC Suppressor cells
Socs Suppressor of Cytokine Signaling
SOCS-1 suppressor of cytokine signalling-1
Su(fu) Suppressor of Fused
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • benign giant cell tumor
    ¾ç¼º °Å´ë¼¼Æ÷ Á¾¾ç
    1. °ñÀÇ ¾ç¼º °Å´ë¼¼Æ÷Á¾. °ñÀÇ ¾ç¼º Á¾¾çÀÇ Çϳª·Î ³ë¾àÀÚ¿¡°Ô ¸¹À¸¸ç ¹ß»ý ºÎÀ§´Â Àå°ü°ñÀÇ °ñ´Ü¿¡ ¸¹ÀÌ ³ªÅ¸³­´Ù. Á¶Á÷ÇÐÀûÀ¸·Î ¿øÇü, ¹æÃßÇüÀÌ ÀÖ´Ù. ¼¼Æ÷ »çÀÌ¿¡ ÆÄ°ñ¼¼Æ÷¿Í À¯»çÇÑ °Å´ë¼¼Æ÷°¡ È¥ÀçÇÑ´Ù. 2. °ÇÃÊÀÇ ¾ç¼º °Å´ë¼¼Æ÷Á¾. º»·¡ Á¾¾çÀÌ ¾Æ´Ï¸ç, °áÁ¤¼º °ÇÃÊ¿°À» °¡¸®Å°¸ç °ÇÃÊÀÇ ¼¶À¯¼º Á¶Á÷±¸Á¾¿¡ Æ÷ÇԵȴÙ.
  • benign melanocytic tumor
    ¾ç¼º ¸á¶ó´Ñ ¼¼Æ÷Á¾
  • benign vascular tumor
    ¾ç¼º Ç÷°üÁ¾
  • beta cell tumor
    º£Å¸ ¼¼Æ÷Á¾
  • beta-cell tumor
    º£Å¸ ¼¼Æ÷ Á¾¾ç
    µµ¼¼Æ÷ Á¾¾ç Áß °¡Àå ÈçÇÑ Áúº´À¸·Î Àν¶¸° °ú´Ù ºÐºñ°¡ ÀϾ´Ù.
  • bladder tumor
    ¹æ±¤ Á¾¾ç
    ¹æ±¤ º®ÀÇ °¢ Á¶Á÷¿¡ ¹ß»ýÇÏ´Â Á¾¾ç. À¯µÎÁ¾, ¼±Á¾, ±ÙÁ¾, ÇǺξçÁ¾, Áö¹æÁ¾, Ç÷°üÁ¾ µî ¾ç¼ºÀÎ °Í°ú ¾Ï, À°Á¾ µî ¾Ç¼ºÀÎ °ÍÀÌ ÀÖÀ¸¸ç, ¾à 10 %¸¸ÀÌ ¾ç¼ºÀÌ°í ´ëºÎºÐÀÌ ¾Ç¼ºÀ¸·Î ¹ß»ý ¿øÀÎÀº ºÒ¸íÀÌ´Ù. ƯÁ¤ ±âÈ£ À½·á³ª ¾à¹°ÀÇ Àå±â ¿¬¿ë µî¿¡ ÀÇÇÏ´Â °Í°ú ¾Æ´Ò¸°°è ¾àǰÀ» Ãë±ÞÇÏ´Â °øÀå ±Ù·ÎÀÚ¿¡°Ô¼­ º¸°Ô µÇ´Â Á÷¾÷ ¾ÏÀÌ ÁÖ¸ñµÇ°í ÀÖ´Ù. ¶ÇÇÑ ¹æ±¤ Á¾¾çÀº Áß³â ÀÌÈÄ¿¡ Àß ¹ß»ýµÇ¸ç ¿©ÀÚº¸´Ù ³²ÀÚ¿¡°Ô ¸¹´Ù. Ãʱâ Áõ¼¼´Â Ç÷´¢¸¦ º¸ÀÌ´Ù°¡ ÀúÀý·Î ¸ÜÀ¸¸ç, ÀÌ·± ÀÏÀÌ ¹Ýº¹µÇ´Â µ¿¾È¿¡ ¹æ±¤¿°, ½Å¿ì½Å¿°À» º´¹ßÇÏ¿© ¹è´¢Åë, ºó´¢, Ç÷³ó´¢¿Í ¿äÅëÀÌ ³ªÅ¸³­´Ù. ¶§·Î´Â ¹æ±¤ ¾È¿¡ ÀÀÇ÷ÀÌ »ý±â°í ¹æ±¤ Ãⱸ¿¡ Á¾¾çÀÌ »ý°Ü ¹è´¢ Àå¾Ö°¡ ¿À±âµµ ÇÑ´Ù. ¹æ±¤°æ °Ë»ç·Î Áø´ÜÇϸç, ħÀ±¼ºÀÌ °­ÇϹǷΠÁ¶±â Áø´Ü ¹× Á¶±â Ä¡·á°¡ ¹Ù¶÷Á÷ÇÏ´Ù. Ä¡·á¹ýÀ¸·Î´Â ¿©·¯ °¡Áö ºñ´¢±â°úÀû ¼ö¼ú¹ý°ú ¹æ»ç¼± ¿ä¹ýÀÌ ÀÖÀ¸¸ç, Á¾¾çÀÇ ¼º»ó°ú ȯÀÚÀÇ ¿¬·É ¹× Àü½Å »óÅ µî¿¡ µû¶ó¼­ ÀÌ µÎ °¡Áö¸¦ Àû´çÈ÷ ¼¯¾î Ä¡·áÇÏ´Â Ä¡·á¹ýÀ» »ç¿ëÇÑ´Ù. ¾Ç¼ºÀÎ °æ¿ì ¹æÄ¡Çϸé ÇÒ¼ö·Ï ¹æ±¤ÀÇ ÁÖº¯ ¹× ¸Ö¸® ¶³¾îÁø ºÎÀ§¿¡µµ ÀüÀÌÇÏ¿© Ä¡À¯µÇ±â ¾î·Á¿öÁø´Ù. Àç¹ßÇϱ⠽¬¿î ÁúȯÀ̹ǷΠġ·á ÈÄ¿¡µµ 1³â¿¡ 3ȸ Á¤µµ ¹Ý¿µ±¸ÀûÀ¸·Î Á¤±â °ËÁøÀ» ¹Þ¾Æ¾ß Çϸç, Ç÷´¢°¡ ³ªÅ¸³ª¸é Áï½Ã ÁøÂûÀ» ¹Þµµ·Ï ÇÑ´Ù.
  • bluish tumor
    Ǫ¸¥ »ö Á¾¾ç
  • bone tumor
    °ñ Á¾¾ç
    óÀ½¿¡ »À¿¡ ¹ß»ýÇÏ´Â Á¾¾ç. ´Ù¸¥ ºÎÀ§¿¡¼­ ¾ÏÀÌ ÀüÀÌÇÏ´Â Àϵµ ÀÖÀ¸³ª, ´ëºÎºÐÀº Á¶°ñ¼¼Æ÷³ª Á¶Á÷ÀÇ ÀÌ»ó Áõ½Ä¿¡ ÀÇÇÏ¿© »ý±ä´Ù. °ñ Á¶Á÷ ÀÚü¿¡¼­ ¹ß»ýÇÏ´Â Á¾¾çÀ¸·Î´Â °ñÁ¾, ¿¬°ñÁ¾ÀÌ ÀÖ°í, »À¿¡ Æ÷ÇÔµÈ °áÇÕÁ¶Á÷¿¡¼­ ¹ß»ýÇÏ´Â ¼¶À¯Á¾, Ç÷°ü¿¡¼­ ¹ß»ýÇÏ´Â Ç÷°üÁ¾, °ñ¼ö¿¡¼­ ¹ß»ýÇÏ´Â °ñ¼öÁ¾ÀÌ ÀÖ´Ù. °ñ¼öÁ¾À» Á¦¿ÜÇϰí´Â ¸ðµÎ ¾ç¼º Á¾¾çÀ¸·Î »ý¸íÀÇ À§ÇèÀÌ µû¸£´Â ÀÏÀº ¾ø°í °ÅÀÇ Å¸°¢ ¼Ò°ß
  • brenner tumor
    ºê·»³Ê Á¾¾ç
    µå¹® ³­¼Ò Á¾¾çÀÌ´Ù. ¾î¸°ÀÌ¿¡¼­ ³ëÀαîÁö ¸ðµç ¿¬·É¿¡ ¹ß»ýµÇ³ª ´ëºÎºÐÀÌ 50¼¼ ÀÌÈÄ¿¡ »ý±ä´Ù. À°¾ÈÀûÀ¸·Î ´ëºÎºÐ °íÇü¼ºÀÌ°í ´Ü´ÜÇÏ¸ç ¼è¹é»öÀ̳ª µå¹°°Ô ÀÛÀº ³¶¼º ºÎÀ§°¡ Àְųª ¿ÏÀüÇÑ ³¶¼ºÀÏ ¼öµµ ÀÖ´Ù. Å©±â´Â 1cm ¹Ì¸¸ÀÇ ÀÛÀº Á¾¾ç¿¡¼­ ¸Å¿ì Å« Á¾¾ç±îÁö ´Ù¾çÇÏÁö¸¸ ´ë°³´Â Á÷°æ 2-8cmÀÌ´Ù. Çö¹Ì°æÀûÀ¸·Î »óÇÇ ¼¼Æ÷¿Í °£Áú ¼¼Æ÷·Î ±¸¼ºµÇ¾î ÀÖ°í »óÇÇ ¼¼Æ÷´Â ¾ãÀº È£»ê¼º ¼¼Æ÷Áú°ú Ÿ¿øÇü ¼¼Æ÷ÇÙÀ» °®´Âµ¥ Ư¡ÀûÀÎ ¼¼Æ÷ÇÙÀÇ "±¸" Áï "Ä¿ÇÇ ¾Ë" ¸ð¾çÀ» ÇÏ°Ô µÈ´Ù. °£Áú ¼¼Æ÷´Â ³­Æ÷¸· ¼¼Æ÷¸¦ ´à±âµµ ÇÑ´Ù. ´Ù¸¥ Á¾¾ç ƯÈ÷ Á¡¾×¼º ³¶¼±Á¾À̳ª ³¶¼º ±âÇüÁ¾°ú ÇÔ²² ¹ß»ýÇÏ´Â °ÍÀÌ Àß ¾Ë·ÁÁ® ÀÖ´Ù.
  • broad based tumor
    ±âÀúºÎ°¡ ³ÐÀº Á¾¾ç
  • calcified epithelial odontogenic tumor
    ¼®È¸È­ »óÇǼº Ä¡¼º Á¾¾ç
  • carotid body tumor
    °æµ¿¸Æ ¼Òü Á¾¾ç
  • cartilaginous tumor
    ¿¬°ñ¼º Á¾¾ç
    Á¶ÀýÇÒ ¼ö ¾øÀ» Á¤µµ·Î °è¼Ó ÁøÇàµÇ´Â ¼¼Æ÷ºÐ¿­¿¡ ÀÇÇÑ ¿¬°ñ Á¶Á÷ÀÇ »õ·Î¿î Áõ½Ä ¹× Áõ´ë.
  • cavernous tumor
    ÇØ¸é»ó Á¾¾ç, ÇØ¸éÁ¾
    µ¿ÀǾî=cavenoma.
  • central giant cell tumor
    Á߽ɼº °Å´ë ¼¼Æ÷ ¾ÏÁ¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
pair rule gene <molecular biology> A segmentation gene, expressed sequentially between gap genes and segment polarity genes. In development of Drosophila, a set of about 8 genes that are expressed only in alternate segments (odd or even) of the developing embryo. Loss of function mutants thus lack alternate segments.
Examples: even skipped (eve), fushi tarazu (ftz), hairy.
(18 Nov 1997)
variable gene <molecular biology> Those regions in the amino acid sequence of both the heavy and the light chains of immunoglobulins where there is considerable sequence variability from one immunoglobulin to other of the same class, in contrast to constant sequence (C) regions. The V regions are associated with the antigen binding areas. They contain hypervariable regions of particularly high sequence diversity.
(18 Nov 1997)
gap gene <molecular biology> Segmentation genes involved in specifying relatively coarse subdivisions of the embryo.
They are expressed sequentially in development between egg polarity genes and pair rule genes. In Drosophila, there are at least three such genes, for example Kruppel.
(18 Nov 1997)
gene <cell biology, molecular biology> Originally defined as the physical unit of heredity, it is probably best defined as the unit of inheritance that occupies a specific locus on a chromosome, the existence of which can be confirmed by the occurrence of different allelic forms.
Genes are formed from DNA, carried on the chromosomes and are responsible for the inherited characteristics that distinguish one individual from another. Each human individual has an estimated 100,000 separate genes.
Given the occurrence of split genes, it might be redefined as the set of DNA sequences (exons) that are required to produce a single polypeptide.
(09 Oct 1997)
gene activation The process of activation of a gene so that it is expressed at a particular time. This process is crucial in growth and development.
(05 Mar 2000)
gene amplification <molecular biology> Selective replication of DNA sequence within a cell, producing multiple extra copies of that sequence. The best known example occurs during the maturation of the oocyte of Xenopus, where the set (normally 500 copies) of ribosomal RNA genes is replicated some 4,000 times to give about 2 million copies.
(18 Nov 1997)
gene bank A group of genes which are coordinately controlled.
(09 Oct 1997)
gene cloning <molecular biology> The insertion of a DNA sequence into a vector that can then be propagated in a host organism, generating a large number of copies of the sequence.
(18 Nov 1997)
gene cluster A set of closely related genes that code for the same or similar proteins and which are usuallygrouped together on the same chromosome.
(09 Oct 1997)
gene conversion <molecular biology> A phenomenon in which alleles are segregated in a 3:1 not 2:2 ratio in meiosis. May be a result of DNA polymerase switching templates and copying from the other homologous sequence or a result of mismatch repair (nucleotides being removed from one strand and replaced by repair synthesis using the other strand as template).
(18 Nov 1997)
gene deletion The total loss (or absence) of a gene. Gene deletion plays a role in birth defects and in the development of cancer.
(12 Dec 1998)
gene disorder Hereditary disorder caused by a mutant allele of a single gene (e.g., Duchenne muscular dystrophy, retinoblastoma, sickle cell disease).
Compare polygenic disorders.
(05 Mar 2000)
gene disruption Use of both in vitro and in vivo recombination to substitute an easily selected mutant gene for a wild-type gene.
(09 Oct 1997)
gene divergence The difference (expressed as a percentage) in the nucleotide sequencesbetween two related genes that developed from the same ancestral gene.
(09 Oct 1997)
gene dosage <molecular biology> Number of copies of a particular gene locus in the genome, in most cases either one or two.
(18 Nov 1997)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
tumor suppressor gene Genes that normally restrain cell growth but, when missing or inactivated by mutation, allow cells to grow uncontrolled. The P53 gene is an example.
Ãâó: www.nexxusscotland.com/media_centre/glossary.html
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á